365telugu.com online news,New Delhi, September 3rd, 2025: The 11th edition of iPHEX 2025 will be held on September 4–5 at Bharat Mandapam, New Delhi, reaffirming India’s position as the “Pharmacy of the World.” Organized by Pharmexcil with the support of the Government of India, the event will bring together global regulators, policymakers, and industry leaders.
This year’s edition will showcase:
- Participation from over 700 Indian exporters.
- 500+ overseas delegates from more than 120 countries.
- Over 20,000 domestic visitors.
- 8,000+ B2B meetings, establishing iPHEX as one of the most business-driven exhibitions worldwide.
Global Regulatory Conclaves – The Highlight of iPHEX 2025
Organized in collaboration with CDSCO and the Ministry of Health & Family Welfare, the conclaves will focus on strengthening international regulatory cooperation and boosting the global recognition of Indian Pharmacopoeia. Key themes include:
- Access to Quality Medicines through Regulatory Convergence – Enabling faster approvals and reducing costs.
- Good Reliance Practices (GRPs) – Leveraging regulatory reliance for timely and affordable market entry.
- Bharat Health Vision 2030 & 2047 – Aligning India’s long-term health roadmap with global ambitions.
- Market Access to Regulated Markets – Strategies for the US, EU, and Japan.
- ROW Opportunities – Expanding in Africa, Latin America, and ASEAN.
- Pharmacopoeia Convergence (BP, IP, USP) – Building trust in Indian generics through harmonized standards.
The conclaves highlight how India’s evolving regulatory ecosystem is shaping global healthcare by promoting affordability, trust, and wider access to medicines.
Read This also…Indus Towers Announces Expansion into African Markets..
India’s Global Role in Focus
Bhavin Mehta, Vice Chairman of Pharmexcil and Chairman of iPHEX 2025, said:
“iPHEX 2025 is not just a trade exhibition—it is a global dialogue on India’s role as the Pharmacy of the World. This year, we expect nearly 8,400 meetings, surpassing last year’s 7,400. Our aim is to harmonize standards, enhance trust in Indian generics, and accelerate access to affordable medicines.”
The Indian Pharmacopoeia will be a central theme at iPHEX 2025, with a goal of expanding its global recognition. Already adopted by 12 countries, efforts are underway to bring another 10–12 nations on board this year.
At its core, iPHEX 2025 serves as a convergence platform where India’s pharmaceutical leadership aligns with global healthcare priorities—powering healthcare access and connecting markets worldwide.